Health Technology Assessment (HTA) is a form of scientific evaluation that examines the short-term and long-term consequences of using medical technology. It is an interdisciplinary process that gathers information on the medical, social, economic and ethical issues associated with the use of medical technology and is carried out in a systematic, transparent, non-discriminatory and evidence-based manner. When there is a lack of data on an issue, HTA can be used to investigate and generate relevant information. HTA is not just about European countries. It is used by healthcare providers around the world and its use is growing.
Medtech Solutions Faithful to its mission can support any company or interested party who wants to substantiate with scientific methodology the added value of its product while supporting it at the critical stages of its approval, pricing and compensation. In this direction it can provide a number of integrated services, the main of which are the following:
- Budget impact analysis
- Cost-effectiveness analysis
- Cost-utility analysis
- Cost-of-illness analysis
- Modeling and simulation
- Payer and pricing research
- Product advisory boards
- Stakeholder analysis
- Strategic consulting
- Value dossiers
- Market size estimation
- Market trends
- Policy trends
- Competition analysis
AtMedtech Solutions We believe that evidence-based knowledge is not only a tool but also a powerful advantage in the hands of any company that wants to achieve the best possible result for its product. In this direction it can provide a number of integrated services, the main of which are the following:
- Epidemiology of disease
- Burden of disease
- Patient quality of life
- Effectiveness of therapy
- Cost of therapy
- Cost effectiveness
- Health care policies
- Health care systems
- Health care markets
. MedTech Solutions has specialized staff who can to substantiate in a scientific way and methodology the added value that a product has while supporting it at the critical stages of its approval, pricing and compensation. It is for this reason that it is most appropriate to operate either in a supportive or direct role in the negotiation processes with the respective institutions.
It is easy for a company to make mistakes in the regulatory process given the multifaceted nature of regulatory authorities and laws. These mistakes can even translate into delays for a company which most of the time can not even be valued in their entirety but will certainly cost dearly. We at MedTech Solutions we can relieve you of the burden of managing the optimal routes provided by each regulatory authority.
After all, our goal is to achieve for you the optimal time that may be required with the lowest administrative and management costs.
Powered by Graphy © 2019.All rights reserved. ©
